Denied

No. 20-779

Argentum Pharmaceuticals LLC v. Novartis Pharmaceuticals Corporation

from the United States Court of Appeals for the Federal Circuit

See other cases from the Federal Circuit.

Docket Entries

Petition DENIED.

Reply of petitioner Argentum Pharmaceuticals LLC filed. (Distributed)

DISTRIBUTED for Conference of 3/19/2021.

Brief of respondent Novartis Pharmaceuticals Corporation in opposition filed.

Response Requested. (Due February 16, 2021)

Brief amicus curiae of Jonathan Stroud filed. (Distributed)

DISTRIBUTED for Conference of 1/22/2021.

Waiver of right of respondent Novartis Pharmaceuticals Corporation to respond filed.

Petition for a writ of certiorari filed. (Response due January 7, 2021)

Parties

Argentum Pharmaceuticals LLC, Petitioner, represented by Teresa Stanek Rea

Novartis Pharmaceuticals Corporation, Respondent, represented by Mark Andrew Perry

Amici Curiae

Jonathan Stroud, Amicus Curiae, represented by Jonathan Rudolph Kominek Stroud

 
Last updated: July 28, 2021